A bioinformatics perspective on proteomics: Data storage, analysis, and integration by Kremer, A. et al.
A Bioinformatics Perspective on Proteomics:
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The ﬁeld of proteomics is advancing rapidly as a result of powerful new technologies and
proteomics experiments yield a vast and increasing amount of information. Data regarding
protein occurrence, abundance, identity, sequence, structure, properties, and interactions
need to be stored. Currently, a common standard has not yet been established and open
access to results is needed for further development of robust analysis algorithms. Databases
for proteomics will evolve from pure storage into knowledge resources, providing a
repository for information (meta-data) which is mainly not stored in simple ﬂat ﬁles. This
review will shed light on recent steps towards the generation of a common standard in
proteomics data storage and integration, but is not meant to be a comprehensive overview of
all available databases and tools in the proteomics community.
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PROTEOMICS, LESS GENES THAN EXPECTED. . .
The term proteome was ﬁrst introduced by Marc Wilkins 10 years ago during a
proteomics meeting in Siena (Italy) to describe the set of proteins encoded and
expressed by the genome. Proteomics is the large scale identiﬁcation and functional
characterization of all expressed proteins in a given cell (in a given state), including
all protein isoforms and modiﬁcations, the protein interaction networks, protein
structure determination and high-order complexes of proteins (Tyers and Mann,
2003). Proteomics is advancing rapidly as the result of powerful new technologies
and experiments yield a vast and increasing amount of data. Experimental infor-
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mation about protein occurrence, abundance, identity, sequence, structure, proper-
ties, and interactions need to be stored. There is currently no common standard or
deﬁnition of the minimum set of information about a proteomics experiment
established. As recently observed in the case of microarray experiments, for any
further development and improvement of data analysis open access to results is
essential. Fundamental issues such as biological variability, pre-analytic parameters
and analytical reproducibility remain to be resolved. Consequently, the analysis of
proteomics data is currently descriptive, often manual and relies mainly on expert
opinions. In the future, databases used in proteomics will increasingly serve as
knowledge resources and provide the repository for diverse information (meta-data),
which will not only be limited to simple ﬂat-ﬁles.
Since the ofﬁcial publication of the ﬁrst draft of the human genome (Lander
et al., 2001; Venter et al., 2001) it is believed that there are between 30,000–40,000
genes. This is far less than the number originally predicted and means that genes
must work in permutations and combinations, which invokes a network with
exponentially increasing interactions. Regulatory networks in biology are acceler-
ating networks, where operations are reliant in the integrated activity of any or all of
the components’ nodes (Mattick and Gagen, 2005). Additionally, simple binary
classiﬁcation often makes no sense in terms of the physiological network. In general,
subtle diﬀerences in the aﬃnity of an interaction will lead to the oﬀ and on switch in
a network. This poses challenges for the current and future databases in life sciences.
Traditional Databases
Common objectives of the majority of databases are maximization of annota-
tion, minimization of redundancy and integration or at least linkage to other da-
tabases. In other words, to provide a parts list which describes molecular and cellular
features from the viewpoint of an evolutionary relationship. The representation of
gene and genome sequence data is fairly well standardized and initially, the main
efforts for protein sequence data have centred around the Swiss-Prot and TrEMBL
databases as well as the Protein Information Resource (PIR). In 2002, the UniProt
consortium was created by SIB, PIR and the EBI. These three collaborating bodies
have pooled their resources to create ‘‘the world’s most comprehensive catalogue of
information on proteins’’ (Apweiler et al., 2004). The triad of databases that form
the basis of UniProt are the Archive (UniParc), the Knowledgebase (UniProt) and
the Non-redundant reference (UniRef) and the system is designed to give easy access
to the available protein information. A second initiative, the protein interactions
database, IntAct, is based on a standard system for the presentation and annotation
of protein-protein interactions. It is a public repository for data from the various
partners and the published literature and a portable version has been created to
facilitate installations on diﬀerent local systems and subsequent (easy) sharing of
data (Hermjakob et al., 2004b).
Until recently, the main purpose of database similarity searches was to detect
homologous sequences, regardless of the species or remoteness of the relationship.
The goal was to infer similarity of function from similarity of sequences and/or to
study the evolution of protein families and domains. In proteomics studies the goal is
slightly different and therefore different strategies and tools are required. Statistical
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signiﬁcance is important, but not in the sense of the probability that two sequences
are related by chance. The objective of a database search in the case of protein
identiﬁcation using mass spectrometry is to ﬁnd an exact, or nearly exact, match
between sub-sequences (peptide fragments) and those sequences encoded by the
genome. Additionally it is often important to identify the presence or absence of a
protein or even alterations of post-translational modiﬁcations (Boguski and McIn-
tosh, 2003).
Information at the level of the proteome is critical for understanding a cellular
phenotype and its implications for normal and disease conditions. Proteome alter-
ations in disease processes occur in many different ways and some of these are not
predictable from genomic analysis. It is clear that a better understanding of these
alterations and their consequences within the biological context will have a sub-
stantial impact in medicine. The identiﬁcation and development of biomarkers for
diagnostics and early detection of disease is of high interest for the pharmaceutical
industry. Moreover, the understanding of biological networks increasingly provides
the rational basis for (preliminary) decisions on drug targets and target suitability
(Hanash, 2003).
CURRENT EFFORTS IN PROTEOMICS DATABASES…
The number of proteomics databases available in the world-wide web is
increasing (Crawford and Garrels, 2000; Wojcik and Schachter, 2000). Selected re-
sources are listed in Table 1 and an up-to-date list of available resources can also be
found in the recent Database Issue of Nucleic Acids Research (http://nar.oupjour-
nals.org/content/vol33/suppl_1/index.dtl). Currently, the generation and the analysis
of proteome data are becoming increasingly popular, and the ﬁeld is moving towards
high-throughput approaches.
Typical 2D PAGE databases store 2D gel images obtained from speciﬁc tissues
or cells. Identiﬁed spots are highlighted and varying amounts of information about
Table 1. Protein Interaction Resources and some URLs of Interest
Database of interacting proteins (DIP) http://dip.doe-mbi.ucla.edu
BIND http://www.bind.ca
MIPS http://mips.gsf.de
Protein–protein interaction database (IntAct) http://www.ebi.ac.uk/intact
Human Protein Reference Database (HPRD) http://www.hprd.org/
Human Protein Interaction Database (HPID) http://www.hpid.org
HUPO http://www.hupo.org/
HUPO PSI http://psidev.sourceforge.net/ http://psidev.sf.net/
Index site: http://www.expasy.ch/ch2d/2d-index.html
The Proteome Analysis DB: http://www.ebi.ac.uk/proteome/
Swiss 2DPAGE http://www.expasy.ch/ch2d/
2DWG Image Meta-database http://www-lecb.ncifcrf.gov/2dwgDB/
PEDRo http://sourceforge.net/projects/pedro
http://pedro.man.ac.uk/
Open Proteomics Database http://bioinformatics.icmb.utexas.edu/OPD/
Systems Biology Institute http://www.systemsbiology.org/
SBEAMS http://www.sbeams.org/
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the identiﬁed proteins are provided. Most structured databases (Table 1) provide
‘‘clickable’’ map functionality as well: clicking on a spot leads the user to a protein
‘‘summary sheet’’, featuring experimental information, annotations and cross-
references to classical protein databases. Gel image analysis may range from very
basic to fairly complex, depending on how much automation is required. Currently,
one major limitation for the development and scale-up of 2D PAGE based analysis is
the gel comparison process. This bottleneck hinders data interpretation and analysis.
Until the output images of diﬀerent 2D PAGE experiments—yielding diﬀerent gel
shapes—can be reliable compared, tedious and time-intensive manual analysis re-
mains necessary.
Today’s principal protein databases emphasize molecular and cellular features
and annotations and are not well suited to represent physiology. To retrieve groups
of proteins based upon known pathways or functional classiﬁcations is currently not
always possible in a reliable or satisfying manner. Reasons for this situation are the
speed at which the proteomics ﬁeld is evolving and the inherited dynamism which
makes it difﬁcult to deﬁne key data and the very complex meta-data needed for
analysis. Furthermore, annotations about post-translational modiﬁcations are still
rare and difﬁcult to locate in a consistent way (Jung et al., 2001). There is also the
challenge of distinguishing annotations merely based on predicted modiﬁcations
(derived from protein motifs) from those based on direct experimental evidence. A
more suitable database would enable to classify proteins from a functional, as well as
an evolutionary viewpoint. Such a data repository would also contain values of
protein concentrations measured for certain conditions (e.g. for cancer tissue at a
certain stage) which could then be compared to concentrations found in non-disease
tissue.
The aim of functional proteomics is to describe the function of a given protein
based on the global pattern of its molecular interactions. Several techniques,
including computational methods are available or start to emerge for the exploration
of the ‘‘interactome’’ (deﬁned as the pattern of interactions of a proteome (Xenarios
and Eisenberg, 2001)). Proteins that interact or are part of the same complex are
generally involved in the same cellular process. The inherent complexity of inter-
action data has led to the design of various data structures to store interaction
information (Eilbeck et al., 1999; Bader and Hogue, 2000; Xenarios et al., 2000).
Earlier interaction databases mainly provided a basic display of the alphabetical
interaction list (with annotations or cross-references to other protein databases) and
some basic query tools. More recent databases tend to structure the ‘‘interactome’’
model in order to oﬀer real navigation tools. Especially large-scale two-hybrid
screens have generated a wealth of information describing potential protein-protein
interactions. When compiled with data from other sources and functional tests, a
network of interactions among proteins and between proteins and other components
of eukaryotic cells can be constructed. These networks can be used to deduce po-
tential signalling pathways, interactive complexes and most importantly provide
clues to the function of previously uncharacterized proteins (Tucker et al., 2001).
The Pathway Resource List (PRL, http://www.cbio.mskcc.org/prl/index.php)
available on the web, is a new database that contains information of 166 internet
pathway resources including protein interaction databases. Due to the fact that
many physical interactions are conserved between species, it should be possible to
98 Kremer, Schneider, and Terstappen
infer information about human protein interactions (and hence protein function)
using model organism protein-interaction datasets (Lehner and Fraser, 2004). There
is also increasing interest in and need for applying proteomics to the identiﬁcation of
disease markers (see also Calvo et al., this issue). Not only the potential of mass
spectrometry to yield comprehensive proﬁles of peptides and proteins in biological
ﬂuids without the need to ﬁrst carry out protein separations has attracted interest. In
principle, such an approach is highly suited for marker identiﬁcation because of
reduced sample requirements and high throughput (Hanash, 2003).
THE NEED FOR A COMMON STANDARD…
Recognizing the disparity in proteomics data storage formats, The Human
Proteome Organization launched the Proteomics Standards Initiative in 2002 with
the main aim ‘‘to deﬁne community standards for data representation in proteomics
to facilitate data comparison, exchange and veriﬁcation’’. Standards are currently
developed for mass spectrometry and protein-protein interaction data, as well as a
general proteomics format. (HUPO Proteomics Standards Initiative, PSI;
(Hermjakob et al., 2004a)). In brief, the workﬂow consists of physical separation of
samples by gel electrophoresis, size-exclusion and/or aﬃnity chromatography,
followed by mass spectrometric examinations and protein identiﬁcation by bioin-
formatics analysis. Over the past few years the number and size of proteomic
datasets composed of mass spectrometry-derived protein identiﬁcations reported in
the literature have been growing dramatically. In part, the need for guidelines is also
driven by the fact that a signiﬁcant but undeﬁned number of proteins being reported
as ‘‘identiﬁed’’ in publications are likely to be ‘‘false positives’’ (Carr et al., 2004). It
is almost always possible to match a MS/MS spectrum to a peptide in the database;
the diﬃcult part is validating that the match is correct. While the accepted standards
for peptide identiﬁcations are MS/MS data, a signiﬁcant portion of the ‘‘proteomics
community’’ continues to employ peptide mass ﬁngerprinting data for peptide
identiﬁcation.
A proposal for a standard representation of both, the methods used and the
data generated in proteomics experiments was presented recently (Taylor et al.,
2003; Garwood et al., 2004a). It is analogous to that of the minimum information
about a microarray experiment (MIAME) guidelines for ‘‘transcriptomics’’ and the
associated microarray gene expression (MAGE) object model including a extensible
mark-up language (XML) implementation. This Proteome Experimental Data
Repository (PEDRo) data model describes in an implementation-independent
manner the data that are required to be captured from a proteomics experiment
(both, results and meta-data). It does not only contain information on protein
separation and identiﬁcation, but includes also detailed descriptions of the experi-
mental samples, the mass spectrometric analyses conducted, the conditions under
which the measurements were taken, the equipment used for these measurements and
the software used to perform protein identiﬁcation. It can be regarded as a ‘‘proof of
concept’’ model that covers most of the workﬂows which are currently followed in
proteomics experiments. Its main intension is to share experimental results and not
to provide a comprehensive query or analysis environment for proteomics data.
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SOFTWARE…
If full use is to be made of such rich data models, they must be associated with
comprehensive software tools for data capture, dissemination and analysis. It is
crucial that software development is linked at an early stage through agreed docu-
mentation, XML-based deﬁnitions and controlled vocabularies that allow different
tools to exchange primary data sets. First efforts are emerging regarding databases
(Potter, 2001; Garwood et al., 2004b) and systems biology software infrastructure
(ISB, http://www.systemsbiology.org/). There are not many Proteome Data
Repository implementations in mySQL or Oracle available. Oracle is used in many
other business areas and also has advantages, especially regarding complex searches
or analyses over datasets. For example, PEDRo has only limited support for relative
protein abundance data (DIGE and stable isotope labelling strategies) partly due to
the lack of generic constructs for representing relationships between diﬀerent types
of measurements (e.g., relative expression readings).
A repository with a more generic focus is the Systems Biology Experiment
Analysis Management System (http://www.sbeams.org/). SBEAMS is an html-based
relational database that allows integration of disparate data types such as from
ICAT and cDNA experiments and was implemented to facilitate data management
at the ISB. For the end user the result is an interactive html window accessible from
any web browser. Since all data from each step of the experiment are ’warehoused’ in
a uniﬁed schema in the RDBMS, quality control and data analysis tasks are greatly
simpliﬁed. It is planned that SBEAMS will be compliant with the emerging MAGE-
OM/ML (Microarray Gene Expression-Object Model/Mark-up Language) speciﬁ-
cation (http://sourceforge.net/ projects/mged) that will combine all previous micro-
array standards such as MAML, GEML, and GeneXML.
A commercial package, ProteinScape was developed in collaboration with
Bruker Daltonik and is used in the HUPO Human Brain pilot phase. ProteinScape
is an integrated bioinformatics platform which handles all essential steps of a pro-
teome study (Bluggel et al., 2004).
The development of statistically sound methods for assignment of protein
identity from incomplete mass spectral data is critical for automated deposition into
databases. Currently, this is still mainly a manual and hence error-prone process.
The knowledge of ‘‘lessons learned’’ from analysis of DNA microarray data,
including clustering, compendium and pattern-matching approaches, should in
principle be transferable to proteomics analysis. Still, populating a database de novo
can take a long time, but creating subsequent data sets which share some aspects of
the experimental set-up will then be signiﬁcantly less time-consuming.
FUTURE DATABASES…
One general issue observed over the last two decades is the very often missing or
incomplete information about the evidence for an annotation. Without a clear
statement as to whether the provided information is based on direct experimental
evidence or based on a theoretical model or prediction method, such an annotation
can be counterproductive or even misleading. This became apparent when theoret-
ical motif, structure and various functional prediction methods were applied and the
100 Kremer, Schneider, and Terstappen
results added to database annotations. An example are annotations on post-trans-
lational modiﬁcations which are still quite rare; evidence for these annotations is
difﬁcult to locate in a consistent way (Jung et al., 2001). There is a strong need in the
near future for much more detailed meta-data describing the experiments itself and
providing additional information on how certain values were generated. Examples of
such meta-data would be the values of protein concentrations and other measurable
attributes in an experiment compared with normal ranges of values in reference
samples, or the description of the algorithms for the applied data normalization. The
ability to identify proteins, which appear or are missing or changing their concen-
tration is becoming crucial for the comparison of normal and disease conditions.
As mentioned before, today’s sequence-centric databases emphasize molecular
and cellular features and annotations and are not very well suited for addressing
physiological aspects. Future databases with a focus on integrative biology must
allow the exploration and retrieval of data from a physiological point of view. A user
should be able to retrieve a group of proteins based on pathways or functional
classiﬁcations, or identify proteins that appear, disappear or show changes in their
abundance under certain conditions (e.g., disease state). To achieve this it will be
necessary to deﬁne key data of an experiment and to provide the very complex meta-
data needed for analysis.
TECHNOLOGY CHALLENGES FOR DATABASES…
The generation and analysis of proteome data are now widespread. As with
other technologies applied and used in biology, it can be anticipated that emerging
high-throughput approaches and techniques will continue to increase complexity.
The lessons learned from genomics (parallelized, miniaturized and automated pro-
cedures) are already applied in proteomics and will provide the basis for the gen-
eration of highly reproducible results. For database providers the high volume
generation technologies leading to ever increasing amounts of data to be stored call
for standard ways to represent data, and an agreed minimum level of annotation. As
seen in the area of expression analysis data this is urgently needed to facilitate the
analysis, dissemination and exchange of proteomics data. Especially the exchange of
data between different research groups can be seen as a current bottleneck in the
expression analysis ﬁeld. Exchange and re-analysis by different research groups is a
necessary prerequisite for the development of more robust and better analysis tools.
Especially in proteomics the challenge will be to distinguish between the biological
variability and the analytical reproducibility.
NEED FOR INTEGRATION
One necessary step regarding the analysis of proteomics data beyond the current
situation (were analysis still relies mainly on human expert interpretation) will be to
access highly standardized heterogeneous external databases. Every dataset in re-
search is of limited use unless it can be integrated dynamically with the diverse
knowledge surrounding genomic sequences, proteins and disease. ’Intelligent data’
approaches are now emerging based on object-oriented programming that are de-
signed to address the complex proteomics challenges more efﬁciently (Hancock
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et al., 2002). Figure 1 shows the complex relationship of questions which need to be
addressed to various extends during the analysis of proteomics data.
Past and current issues regarding integrating life science databases in general
were summarized in recent overviews (Eilbeck et al., 1999; Ko¨hler, 2004; Searls,
2005). It is often necessary to integrate ‘‘derived data’’ such as conclusions and not
only raw data. Also in this regard the aspect of data quality and its control are
crucial since integration of data ’interpretations’ made by experts carries the risk of
inconsistencies and human bias. The current database concepts need to be improved
in order to integrate complex information about cellular regulation, pathways,
networks and cellular roles (Tucker et al., 2001). The combination of results from
transcriptomic and proteomic experiments, combined with data generated from
biomedical, genetic and metabonomic approaches, protein interaction studies, model
organism biology and clinical analyses, will become a useful tool for the individual
researcher to build and test hypotheses (Eilbeck et al., 1999; Basik et al., 2003;
Hegde et al., 2003; Ko¨hler, 2004; Searls, 2005). But practical and biological diﬀer-
ences exist regarding proﬁling the transcriptome and proteome in parallel. While
current databases are suﬃcient for analysis of a particular protein or small inter-
action networks, they are not as useful for the integration of complex information
about cellular regulation, pathways, networks and cellular roles, and they lack
coordination and the ability to exchange information between multiple data sources
(Tucker et al., 2001). Thus, it is still necessary to signiﬁcantly improve the way in
which data from functional genomics approaches (e.g., microarray-based expression
proﬁles, etc.) and proteomic results are integrated. The resulting comprehensive
Fig. 1. The relationship questions in proteomics.
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databases of gene function will serve as a powerful reference of protein properties
and functions. The well-established relational database systems and ﬂat-ﬁle retrieval
systems (being commercial or open-source) are fundamental underlying technology
stacks for bioinformatics. However, it is data format and exchange, rather than the
database software itself, which needs attention. The wide use of XML as an ex-
change format and the increasing number of web-services will aid the process of
integrating data from diﬀerent sources.
A rich area for improvement is the ﬁeld of terminology. Storing complex data
with a wide range of concepts and models for the various aspects of a biological
system is and will stay a challenge. Since the terminology in biology is in constant
ﬂow and still being developed, the situation of incompatible terminology and
uncontrolled vocabulary is an issue. Despite the current efforts to establish a variety
of ontologies, major problems in constructing uniform queries across many data-
bases remain due to the lack of specifying the meaning and information content of a
biological entity in an automatic fashion. In this respect, the ‘‘free-for-all’ naming
convention used by biologists is certainly an additional barrier (Petsko, 2002; Povey
and Wain, 2002).
Information at the level of the proteome is essential for understanding the
function of a cellular phenotype and its role in health and disease. The ongoing
major collaborative efforts to collate and present publicly available proteomics data
as well as efforts to standardize data formats will still need some time, but the
improved understanding of biological networks will certainly result in greater
knowledge of living systems and ultimately have a substantial impact in medicine.
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